Increasing drug resistance of Mycobacterium tuberculosis in a medical center - What about in Taiwan overall?

Journal of the Formosan Medical Association

Volumn 108, Issue 1, 2009, Pages 1-3

  Chiang, Chen Yuan ^a,b   Kim, Sang Jae ^a  

^a INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^b NONE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANAMNESIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; DISEASE CLASSIFICATION; DISEASE SURVEILLANCE; HEALTH CARE FACILITY; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; LABORATORY TEST; LUNG TUBERCULOSIS; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; QUALITY CONTROL; REFERENCE VALUE; SAMPLE SIZE; SAMPLING; SYSTEMATIC ERROR; TAIWAN; WORLD HEALTH ORGANIZATION;

EID: 60149110501     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(09)60025-5     Document Type: Article

References (21)

1. David HL. Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis. Appl Microbiol 1970;20:810-4.
2. World Health Organization. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surueillance. Anti-tuberculosis Drug Resistance in the World. Geneva: WHO Document 1997;WHO/TB/ 97.229:1-227.
3. World Health Organization. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surueillance. Anti-tuberculosis Drug Resistance in the World. Report No. 2 - Prevalence and Trends. Geneva: WHO Document 2000;WHO/CDC/TB/2000.278:1-253.
4. World Health Organization. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-tuberculosis Drug Resistance in the World. Report No. 3. Geneva: WHO Document 2004;WHO/ CDS/TB/2004.343:1-129.
5. World Health Organization. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-tuberculosis Drug Resistance in the World. Report No. 4. Geneva: WHO Document 2008;WHO/ HTM/TB/2008.394:1-120.
6. Van Deun A, Salim AH, Daru P, et al. Drug resistance monitoring: combined rates may be the best indicator of programme performance. Int J Tuberc Lung Dis 2004;8: 23-30.
7. Zhang LX, Kan GQ, Tu DH, et al. Trend of initial drug resistance of tubercle bacilli isolated from new patients with pulmonary tuberculosis and its correlation with the tuberculosis programme in Beijing. Tuber Lung Dis 1995;76: 100-3.
8. Kam KM. Yip CW. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment. Int J Tuberc Lung Dis 2001;5:815-23.
9. World Health Organization. Guidelines for the Surveillance of Drug Resistance in Tuberculosis. Geneva: WHO Document 2003;WHO/TB/ 2003.320:1-21.
10. Su WJ, Lee PY, Yu KW, et al. Drug resistance of Mycobacterium tuberculosis from patients at a medical center in Taiwan. Chung Hua I Hsueh Tsa Chih 1997;60:21-7.
11. Wang PD, Lin RS. Drug-resistant tuberculosis in Taipei, 1996-1999. Am J Infect Control 2001;29:41-7.
12. Chiang IH, Yu MC, Bai KJ, et al. Drug resistance patterns of tuberculosis in Taiwan. J Formos Med Assoc 1998;97:581-3.
13. Yu MC, Suo J, Chiang CY, et al. Initial drug resistance of Mycobacterium tuberculosis in Taiwan. J Formos Med Assoc 1997;96:890-4.
14. Lu PL, Lee YW, Peng CF, et al. The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996-2000. Int J Antimicrob Agents 2003;21:239-43.
15. Lee JJ, Lee CN, Suo J, et al. Drug resistance of Mycobacterium tuberculosis in eastern Taiwan. Tzu Chi Med J 2003;15:229-34.
16. Liaw YS, Hsueh PR, Yu CJ, et al. Drug resistance pattern of Mycobacterium tuberculosis in a university hospital in Taiwan, 1998-2002. J Formos Med Assoc 2004;103:671-7.
17. Liu CE, Chen CH, Hsiao JH, et al. Drug resistance of Mycobocterium tuberculosis complex in central Taiwan. J Microbiol Immunol Infect 2004;37:295-300.
18. Su WJ, Feng JY, Huang CC, Perng RP. Increasing drug resistance of Mycobacterium tuberculosis isolates in a medical center in northern Taiwan. J Formos Med Assoc 2008;107:259-64.
19. Chiang CY, Hsu CJ, Huang RM, et al. Antituberculosis drug resistance among retreatment tuberculosis patients in a referral center in Taipei. J Formos Med Assoc 2004; 103:411-5.
20. NCCLS. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinamycetes; Approved Standard. Pennsylvania: NCCLS Document M24-A, 2003, page 33 (ISBN 1-56238-500-3).
21. Laszlo A, Rahman M, Espinal M, Raviglione M. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998. Int J Tuberc Lung Dis 2002;6:748-56.